Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02941302 : Multimodality Imaging Combined With Multiple Targets Pathological Examination for Detecting of Biological Borders of Gliomas: a Clinical Application Study
PhaseN/A
AgesMin: N/A Max: N/A
Eligibility
Inclusion Criteria:

- Histologically confirmed, newly diagnosed intracranial glioma

- A diagnostic contrast enhanced CT/MRI demonstrating the lesion prior to registration

- Patient must sign a study specific informed consent form; if the patient's mental
status precludes his/her giving informed consent, written informed consent may be
given by the patient's legal representative

Exclusion Criteria:

- Patient without brain gliomas

- Inability to obtain histological proof of glioma (functional domain and particular
domain)

- Psychiatric conditions precluding informed consent

- Patients who cannot tolerate operation

- Patients who are pregnant or breast feeding

- Urine pregnancy test will be performed on women of child bearing potential
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02941302      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740